Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

source : Www.vynetherapeutics.com    save search

SEC Filing: Form 4
Published: 2023-07-05 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 3.72% C: 3.47%


SEC Filing: Form 4
Published: 2023-06-02 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -1.31% H: 6.64% C: 0.66%


VYNE Investor Relations Presentation
Published: 2023-05-15 (Crawled : 16:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 0.14% H: 6.56% C: 6.08%

presentation
SEC Filing: Form 10-Q
Published: 2023-05-11 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 12.54% C: 2.01%


SEC Filing: Form 8-K
Published: 2023-05-11 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 12.54% C: 2.01%


SEC Filing: Form 8-K
Published: 2023-05-01 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 18.63% C: 14.83%


VYNE Therapeutics Announces Selection of Development Candidate VYN202, a Potential Best-in-Class Oral Small Molecule BD2-Selective BET Inhibitor for the Treatment of Immuno-Inflammatory Conditions
Published: 2023-05-01 (Crawled : 12:20) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 18.63% C: 14.83%

vyn202 candidate treatment therapeutics potential
VYNE Investor Relations Presentation
Published: 2023-04-20 (Crawled : 12:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -7.17% H: 9.9% C: 5.8%

presentation
VYNE Therapeutics Announces Positive Preclinical Data for Inhaled Formulation of VYN201 in an In Vivo Model of Idiopathic Pulmonary Fibrosis
Published: 2023-04-19 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 7.03% H: 50.75% C: 33.13%

vyn201 positive fibrosis preclinical therapeutics
SEC Filing: Form 4
Published: 2023-04-04 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -1.01% H: 6.83% C: -2.43%


VYNE Investor Relations Presentation
Published: 2023-03-30 (Crawled : 12:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 2.5% H: 13.53% C: 13.53%

presentation
SEC Filing: Form 4
Published: 2023-03-22 (Crawled : 21:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.37% C: -5.95%


VYNE Therapeutics to Participate in the H.C. Wainwright Autoimmune & Inflammation Disease Virtual Conference
Published: 2023-03-22 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.37% C: -5.95%

conference disease therapeutics
SEC Filing: Form 10-K
Published: 2023-03-14 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 5.39% H: 2.71% C: -5.12%


VYNE Therapeutics Reports Year-End 2022 Financial Results and Provides Business Update
Published: 2023-03-09 (Crawled : 23:00) - vynetherapeutics.com
DERM | $5.69 14.49% 12.65% 320K twitter stocktwits trandingview |
| | O: -3.33% H: 6.9% C: 3.45%
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -1.31% H: 1.32% C: -0.66%

therapeutics financial update results
SEC Filing: Form 8-K
Published: 2023-03-09 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -1.31% H: 1.32% C: -0.66%


VYNE Investor Relations Presentation
Published: 2023-03-01 (Crawled : 14:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -1.05% H: 0.0% C: -9.7%

presentation
SEC Filing: Form 8-K
Published: 2023-02-28 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -0.37% H: 0.97% C: -0.08%


VYNE Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference
Published: 2023-02-22 (Crawled : 13:20) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: -0.29% H: 1.39% C: -0.88%

care conference health therapeutics
VYNE Therapeutics Announces Positive Results from Phase 1a Single and Multiple Ascending Dose Trial for Investigational Novel BET Inhibitor VYN201
Published: 2023-02-15 (Crawled : 14:00) - vynetherapeutics.com
VYNE | $3.39 0.3% 0.29% 30K twitter stocktwits trandingview |
Health Technology
| | O: 2.0% H: 11.48% C: -1.68%

vyn201 trial therapeutics positive
Gainers vs Losers
55% 45%

Top 10 Gainers
ZVSA | $2.03 3179.48% 96.95% 330K twitter stocktwits trandingview |

CHSN | $4.89 68.63% 45.9% 5.7M twitter stocktwits trandingview |

ANY M | $1.72 60.75% 37.79% 26M twitter stocktwits trandingview |
Technology Services

VCXA | News 0 d | $15.88 60.57% 37.72% 82K twitter stocktwits trandingview |

CNET | News | $1.12 60.0% 37.5% 3.8M twitter stocktwits trandingview |
Commercial Services

MFH | $1.62 37.29% 27.16% 6.5M twitter stocktwits trandingview |
Technology Services

AIHS | $0.4389 37.16% 27.09% 230K twitter stocktwits trandingview |
Finance

KALA | $8.83 36.06% 26.5% 2.7M twitter stocktwits trandingview |
Health Technology

JNVR | $1.53 29.66% 21.33% 2.8M twitter stocktwits trandingview |

WHLR 4 | $0.3532 26.14% 20.72% 14M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.